Therapeutic Group

Indication Dosage

Paclitaxel is a medication primarily used to treat various types of cancer, including breast, lung, ovarian, and pancreatic cancers. It functions as a chemotherapy drug by inhibiting the growth and spread of cancer cells in the body. Paclitaxel is often prescribed in combination with other anticancer medications and is effective in cases where cancer has metastasized or proven resistant to other treatments. It works by disrupting the normal division and growth of cancer cells, ultimately slowing down or preventing their proliferation.

Treatment Of Ovarian Cancer In Combination With Cisplatin: 

By IV Inj: 

• Adults: 175 Mg/m2 Over 3 Hr Or 135 Mg/m2 Over 24 Hr Every 3 Week. 

Treatment Ofmetastatic Ovarian Cancer Where Platinum-containingtherapy Has Failed: 

By IV Inj: 

• Adults: 135-175 Mg/m2 Over 3 Hr Every 3 Week. 

Treatment Of Locally Advanced Or Metastatic Breast Cancer (in Combination Or Alone), Adjuvant Treatment Of Node-positive Breast Cancer Following Treatment With Anthracycline And Cyclophosphamid: 

By IV Inj: 

• Adults: 175 Mg/m2 Over 3 Hr Every 3 Week. 

Treatment Of Non-small Cell Lung Cancer (in Combination With Cisplatin) When Surgery Or Radiotherapy Not Appropriate: 

By IV Inj: 

• Adults: 135 Mg/m2 Over 24 Hr Every 3 Week. 

Treatment Of Advanced Aids-related Kaposi'ssarcoma Where Liposomal Anthracycline Therapy Has Failed, First-linetreatment Of Metastatic Adenocarcinoma Of Thepancreas (in Combination With Gemcitabine): 

By IV Inj: 

• Adults: 135 Mg/m2 Over 3 Hr Every 3 weeks or 100 Mg/m2 Over 3 Hr Every 2 Week. 
• Children: Not Applicable.

Content

Pregnancy

Contraindication In Pregnancy

Stability

Contra Indications

Precautions

Lactation

Side Effects